Maynard Um
-
-
-
-
-
-
-
ArriVent BioPharma (AVBP) PT Lowered to $43 at Citi
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on ArriVent BioPharma (AVBP)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on ArriVent BioPharma (AVBP)
-
-
-
-
-
-
-
ArriVent BioPharma (AVBP) PT Raised to $40 at Citi, Adding 90d Upside Catalyst Watch
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on ArriVent BioPharma (AVBP)
-
-
-
-
-
-
-
ArriVent BioPharma (AVBP) PT Raised to $30 at H.C. Wainwright
-
-
444,237 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

